Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-080866
Filing Date
2023-07-13
Accepted
2023-07-13 18:39:46
Documents
2
Period of Report
2023-07-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2321017-6_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2321017-6_3seq1.xml 3 4658
2 EXHIBIT 24 tm2321017d6_ex24.htm EX-24 6888
  Complete submission text file 0001104659-23-080866.txt   13123
Mailing Address 7 BRYANT PARK 23RD FLOOR NEW YORK CITY NY 10018
Business Address 650-475-3734
Shah Nimish P (Reporting) CIK: 0001698082 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41740 | Film No.: 231087663

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Issuer) CIK: 0001974640 (see all company filings)

EIN.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)